IMV Market Report on U.S. Oncology Facilities Indicates Treatment Visits Remain Relatively Flat Over the Last 4 Years

Apr 11, 2001, 01:00 ET from IMV Medical Information Division, Inc.

    DES PLAINES, Ill., April 11 /PRNewswire/ -- For the third time since 1996,
 IMV Medical Information Division (IMV) has quantified the use of radiation
 therapy and profiled more than 85% of all identified radiation therapy centers
 (1,860 hospital and non-hospital sites) in the United States.  Based on these
 responses, it is estimated that in 1999, 19.3 million radiation therapy
 treatment visits were conducted, with an additional 3.3 million in allied
 visits. The distribution of treatment vs. allied visits has been relatively
 constant to those reported in 1997, where the combined total was estimated as
 20.8 million visits.
     "Prostate and breast cancers were the two highest volume treatment types
 for radiation therapy, each accounting for 19% of all treatment visits.  The
 findings show a dramatic increase in both stereotactic radiosurgery treatment
 volume and the number of sites performing these procedures," noted Mitchell
 Goldburgh, general manager of IMV.  "There were also increases in radionuclide
 therapy and high dose brachytherapy irradiation, illustrating a shift in
 treatment patterns from prior research reports.  As a result, oncology sites
 report significant growth in radioactive agent therapy budgets."
     IMV's Radiation Oncology Market Summary Report details the levels of
 patient visits, types of treatments being performed, as well as the installed
 base of radiation therapy and treatment planning equipment, planned purchases
 and annual budgets for radioactive agents.  The report also reveals staffing
 patterns and operational productivity measures.
     The Radiation Oncology Census Database is available for license to
 qualified subscribers, which includes contact information, leads and survey
 results.  The Market Summary Report is available from IMV for $5,500.  IMV
 also performs customized analysis of the statistics to address specific
 provider or vendor analytical requirements.
     IMV Medical Information Division, Inc. (formerly Technology Marketing
 Group) is a marketing research and consulting firm founded in 1977
 specializing in medical and other advanced healthcare technology markets.
 IMV's proprietary marketing consulting services, in combination with our
 census databases of more than 80% of all U.S. imaging sites with selected
 modalities, provides vendors and health care providers valuable assistance in
 strategic planning, market development and sales initiatives.  Current census
 databases include angiography, CT, MRI, nuclear medicine, fluoroscopy, cardiac
 catheterization, echocardiography, PET, and PACS.
 
 

SOURCE IMV Medical Information Division, Inc.
    DES PLAINES, Ill., April 11 /PRNewswire/ -- For the third time since 1996,
 IMV Medical Information Division (IMV) has quantified the use of radiation
 therapy and profiled more than 85% of all identified radiation therapy centers
 (1,860 hospital and non-hospital sites) in the United States.  Based on these
 responses, it is estimated that in 1999, 19.3 million radiation therapy
 treatment visits were conducted, with an additional 3.3 million in allied
 visits. The distribution of treatment vs. allied visits has been relatively
 constant to those reported in 1997, where the combined total was estimated as
 20.8 million visits.
     "Prostate and breast cancers were the two highest volume treatment types
 for radiation therapy, each accounting for 19% of all treatment visits.  The
 findings show a dramatic increase in both stereotactic radiosurgery treatment
 volume and the number of sites performing these procedures," noted Mitchell
 Goldburgh, general manager of IMV.  "There were also increases in radionuclide
 therapy and high dose brachytherapy irradiation, illustrating a shift in
 treatment patterns from prior research reports.  As a result, oncology sites
 report significant growth in radioactive agent therapy budgets."
     IMV's Radiation Oncology Market Summary Report details the levels of
 patient visits, types of treatments being performed, as well as the installed
 base of radiation therapy and treatment planning equipment, planned purchases
 and annual budgets for radioactive agents.  The report also reveals staffing
 patterns and operational productivity measures.
     The Radiation Oncology Census Database is available for license to
 qualified subscribers, which includes contact information, leads and survey
 results.  The Market Summary Report is available from IMV for $5,500.  IMV
 also performs customized analysis of the statistics to address specific
 provider or vendor analytical requirements.
     IMV Medical Information Division, Inc. (formerly Technology Marketing
 Group) is a marketing research and consulting firm founded in 1977
 specializing in medical and other advanced healthcare technology markets.
 IMV's proprietary marketing consulting services, in combination with our
 census databases of more than 80% of all U.S. imaging sites with selected
 modalities, provides vendors and health care providers valuable assistance in
 strategic planning, market development and sales initiatives.  Current census
 databases include angiography, CT, MRI, nuclear medicine, fluoroscopy, cardiac
 catheterization, echocardiography, PET, and PACS.
 
 SOURCE  IMV Medical Information Division, Inc.